The use of molecular markers in selecting therapy for CLL. (Record no. 15799431)

MARC details
000 -LEADER
fixed length control field 00831 a2200241 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515001612.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200510s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1543-0790
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Döhner, Hartmut
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20051028
245 00 - TITLE STATEMENT
Title The use of molecular markers in selecting therapy for CLL.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical advances in hematology & oncology : H&O
Date of publication, distribution, etc. Feb 2005
300 ## - PHYSICAL DESCRIPTION
Extent 103-4 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers, Tumor
General subdivision biosynthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chromosome Aberrations
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Lymphocytic, Chronic, B-Cell
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
773 0# - HOST ITEM ENTRY
Title Clinical advances in hematology & oncology : H&O
Related parts vol. 3
-- no. 2
-- p. 103-4

No items available.